Navigation Links
Also in the April 7 JNCI
Date:4/7/2009

Subsequent Malignancy a Major Cause of Death in Long-Term Survivors of Hereditary Retinoblastoma

Long-term survivors of hereditary retinoblastoma are at an increased risk of death due to a second cancer, according to a large cohort study.

Retinoblastoma is a very rare cancer of the eye that affects approximately 300 children in the U.S. each year. Survivors of retinoblastoma are at risk of subsequent malignancies but information on the risk of death due to these subsequent cancers is limited among long-term survivors.

In the current study, Chu-Ling Yu, Sc.D., of the National Cancer Institute in Rockville, Md., and colleagues examined the cause of death in a cohort of 1,092 survivors of hereditary retinoblastoma and in 762 survivors of nonhereditary retinoblastoma who were diagnosed between 1914 and 1996.

The mortality rate due to cancers was 35-fold higher in the hereditary retinoblastoma survivors and 2.5-fold higher in the survivors of nonhereditary retinoblastoma, compared with the general population. A total of 151 hereditary retinoblastoma survivors died due to a subsequent cancer, as did 12 survivors of nonhereditary retinoblastoma. Hereditary retinoblastoma survivors were at particular risk of death due to sarcoma, melanoma, and cancers of the brain and nervous system; the risk extended more than 40 years after their initial diagnosis.

"The temporal patterns of site-specific excess risks of subsequent malignant neoplasms in retinoblastoma survivors should inform screening programs designed for the early detection and treatment of subsequent malignant neoplasms," the authors write. Contact NCI press office, ncipressofficers@mail.nih.gov, 301-496-6641


Disruption of Cytokine Signaling Promotes Gastric Cancer Growth in Mouse Models

Disruption of transforming growth factor- (TGF-) signaling in gastric cancer c
'/>"/>

Contact: Caroline McNeil
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Blue Cross and Blue Shield Companies to Host Second Annual National Walk @ Lunch Day(SM) on April 30, 2008
2. Experimental Biology 2008 Todays Research: Tomorrows Health, April 5-9
3. Parental Alienation Awareness Organization Begins Preparations for Parental Alienation Awareness Day - April 25th
4. Sundance Channel to Premiere Documentary Autism Every Day on World Autism Awareness Day, April 2nd at 8:00pm et/pt
5. Dr. Oliver Sacks, NYT Bestselling Author, to Inspire and Marc Black, Award-winning Musician, to Perform at National Aphasia Association Benefit on April 1, NYC
6. TRIZCON2008 at Kent State, April 13-15
7. Hazelden President and CEO Ellen Breyer to Step Down April 4
8. Media Invited to Attend International Society for Heart & Lung Transplantation Meeting in Boston, April 9-12
9. News and features abound at ACS National Meeting in New Orleans, April 6-10
10. COMEDY CENTRAL(R) Announces Live On-Air Charity Special Night Of Too Many Stars: An Overbooked Benefit For Autism Education Hosted by Jon Stewart on Sunday April 13, at 8 p.m. ET
11. 2008 Building Biology(R) Conference, April 19th & 20th, Hotel Radisson at Opryland, Nashville, Tennessee

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...Logic today announced MathMagic Personal Edition 4...tor. With a focus on the equation quality and ease...e equation editor for mathematical equations and s...y standard mathematical expressions including LaTe...Docs and Zoho Writer, and other enhanced features....
(Date:12/4/2009)...ibOx, a leading developer of novel and effective c...d forces with MolPort, an innovator in rare chemic...mical trading platform and builds database of comm...database and its updates to computational chemists...tual screening procedures. Once they identify suit...
(Date:12/4/2009)...h American Seminars Inc. is now accepting medical ...ucation courses at their medical facility in 2010....eration and capabilities to the medical community ...heir physical therapy and occupational therapy tea...250 live training events. , ...
(Date:12/4/2009)...lliSoft Group offers their new IntelliChoice upgra...ialing software, IntelliSoft Group is the only ven...oyment option. ,SaaS is an excellent option for th...ints, yet are in need of medical credentialing sof... 4, 2009 -- ISG Group, LLC, doing business as Inte...
(Date:12/4/2009)...tar fasciitis heel pain affects over two million p...rapy has been cited by the American Academy of Ort... In response to these findings, Orthotics And Bey...rapy systems for plantar fasciitis treatment as a ... therapies. , (PRWEB) Dec...
Breaking Medicine News(10 mins):Health News:MathMagic Personal 4.8 for Windows Now Supports Google Docs and Zoho Equation 2Health News:MathMagic Personal 4.8 for Windows Now Supports Google Docs and Zoho Equation 3Health News:MathMagic Personal 4.8 for Windows Now Supports Google Docs and Zoho Equation 4Health News:InhibOx and Molport Join Forces to Deliver Integrated Lead Design and Delivery 2Health News:InhibOx and Molport Join Forces to Deliver Integrated Lead Design and Delivery 3Health News:North American Seminars Inc. Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program 2Health News:North American Seminars Inc. Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program 3Health News:North American Seminars Inc. Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program 4Health News:IntelliSoft Group Focuses on Protecting Customer Investment in Medical Credentialing Systems -- Budget Constraints and Forced Upgrades in Medical Credentialing Automation 2Health News:Orthotics And Beyond Introduces Compressive Cold Therapy Products for Plantar Fasciitis Treatment 2
...aching Offers Relief to Families Nationwide, SHOR...,life coach and certified parent coach, Tammy Gold...d children at a New York City mental health,clinic...ir upbringing were the real issues. The demands an...
...ney General on physician evaluations will have,nat...atement is,attributable to Nancy H. Nielsen, M.D.,...al Association (AMA) welcomes today,s announcement...king programs. Aetna,s decision to join CIGNA in a...
... iFire Technology Corp., CALGARY, Nov. 13 /PRNews...d today that for the third quarter ended September... or 18 cents per share, on revenues of,$7.8 millio...uarter of 2007, the Company recorded reorganizatio...
...plications for humans, researchers say , TUESDAY,...ydrate diet slowed prostate tumor growth, possibly...sulin production, U.S. researchers say. , "This st...mplications for prostate cancer therapy through so...
...en people with diabetes are walking around in the ...foot problems that could lead to amputation, accor...e International Journal of Clinical Practice. , ...ys that ulceration can have serious implications f...
...3, 2007 For the millions of Americans whose nativ... road block to quality healthcare, according to a ...hers in the Center for Health Policy Research in t...cal errors and lower patient satisfaction. , In...
Other Medicine News:Health News:New Practice Brings Sanity and Support to Parents 2Health News:AMA Commends Aetna for Quality First Commitment 2Health News:Westaim announces 2007 third quarter results 2Health News:Westaim announces 2007 third quarter results 3Health News:Westaim announces 2007 third quarter results 4Health News:Low-Carb Diet May Slow Prostate Tumor Growth 2Health News:63 percent of diabetics risk serious foot problems by wearing the wrong-sized shoes 2Health News:Language barriers adversely impact health-care quality 2
(Date:12/3/2009)...Pa., Dec. 3 Radiology imaging lead...d integration capabilities at the November 2009 Ra... Connect.PACS(TM) product, enabling the first rad...e latest release in the company,s newly branded C... http://www.newscom.com/cgi-bin/prnh/20091203/NE...
(Date:12/3/2009)... In response to the incr...echnologies in the evolving healthcare delivery sy...r Health Informatics (DCHI) to provide a campus fo...nnovative interdisciplinary approach to education ...nurses and healthcare administrators with an exper...
(Date:12/3/2009)... Apnex Medical, Inc., a private me...ted a second round of private equity financing tot...ete a clinical study and develop a second generati...ned to treat obstructive sleep apnea (OSA). ,, ...iates, New Enterprise Associates (NEA), Polaris Ve...
Breaking Medicine Technology:MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3Duke Medicine to Train Healthcare Professionals in Health Informatics 2Duke Medicine to Train Healthcare Professionals in Health Informatics 3Apnex Medical, Inc. Raises Additional $14 Million 2Apnex Medical, Inc. Raises Additional $14 Million 3InfoLogix Selected by Hilo Medical Center for Multi Year Engagement to Deliver Wireless as a Service 53837 1InfoLogix Selected by Hilo Medical Center for Multi Year Engagement to Deliver Wireless as a Service 53837 2InfoLogix Selected by Hilo Medical Center for Multi Year Engagement to Deliver Wireless as a Service 53837 3Living in U S May Raise Hispanics Cancer Risk 53835 1Living in U S May Raise Hispanics Cancer Risk 53835 2Living in U S May Raise Hispanics Cancer Risk 53835 3Oncothyreon announces webcast of second quarter 2009 financial results conference call 13414 1
...s Corporation (Nasdaq: DVAX ) today reported that...weed allergy therapy, to subjects as,part of an en...d to enroll,a total of 300 subjects. Subjects are ...gy and a positive skin test. Exposure to ragweed a...se individuals with confirmed,ragweed allergic dis...
...nsistently Positive Clinical ...ta presented today from,Abbott,s SPIRIT III U.S. p...ive, statistically significant clinical results fo...nt System at one year, including continued,clinica...E) and continued,non- inferior rates of target ves...
Other Medicine Technology:Dynavax Begins TOLAMBA(TM) Environmental Exposure Chamber Study 2Dynavax Begins TOLAMBA(TM) Environmental Exposure Chamber Study 3Abbott's XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial 2Abbott's XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial 3Abbott's XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial 4Abbott's XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial 5
House Teflon Coated Elevator
Cleft Palate Elevator
Louisville Elevator
Converse Periosteal Elevator
Medicine Products: